Long-term Results Continue to Show a Benefit with Nivolumab and Ipilimumab
There is good news for patients with melanoma who received immunotherapy. Survival results from a major clinical trial, CheckMate-067, show…
09/15/2024
Long-term Results Continue to Show a Benefit with Nivolumab and Ipilimumab
There is good news for patients with melanoma who received immunotherapy. Survival results from a major clinical trial, CheckMate-067, show…
|
09/15/2024
Ten Years of Pembrolizumab Shows Sustained Results
There is good news for patients with advanced melanoma who received pembrolizumab. Results from a clinical trial after ten years…
|
09/15/2024
Oncolytic Virotherapy Shows Promise in Advanced Melanoma that Failed Immunotherapy
New clinical trial data shows that additional options may soon become available for patients with melanoma for whom immunotherapy did…
|
09/15/2024
New Therapies Under Investigation for Patients With Metastatic Uveal Melanoma
Results from a Phase 2 clinical trial for patients with advanced uveal melanoma were presented at ESMO 2024 on September…
|
09/14/2024
News from ESMO: NADINA Trial Update in Stage III Melanoma
A follow-up report with data from NADINA was presented at the European Society for Medical Oncology (ESMO) Congress on September…
|
09/11/2024
Restful Recovery: Navigating Sleep and Cancer with Dr. Daniel Barone
Join us for an insightful episode of “Restful Recovery,” where we explore the crucial interplay between sleep and cancer with…
|
09/01/2024
Ways to Give: What Is Payroll Giving?
If you’re seeking a straightforward way to support AIM at Melanoma and maximize your impact, consider signing up for payroll…
|
08/26/2024
Side Effect Central – Colitis
Side Effect Central is a new series of articles designed to help patients with melanoma and their caregivers understand the…
|
08/26/2024
New Specialty Manages Skin Concerns and Keeps Patients on Therapy
Cancer treatment—including and especially melanoma—unfortunately, produces a risk of side effects impacting the feeling and vitality of the skin. Changes…
|
08/01/2024
From Tanning Beds to Sun Safety: Brittanny Groover’s Journey of Melanoma Awareness and Advocacy
Brittanny Groover grew up in a small town in Pennsylvania and spent her childhood outside, playing, riding her bicycle, and…
|
Recent Posts
Sep. 15, 2024
Long-term Results Continue to Show a Benefit with Nivolumab and Ipilimumab
Sep. 15, 2024
Ten Years of Pembrolizumab Shows Sustained Results
Sep. 15, 2024
Oncolytic Virotherapy Shows Promise in Advanced Melanoma that Failed Immunotherapy
Sep. 15, 2024
New Therapies Under Investigation for Patients With Metastatic Uveal Melanoma
Sep. 14, 2024